Figitumumab - CAS 943453-46-1

Figitumumab (CP-751871) is a highly potent, fully human monoclonal antibody of the IgG2 isotype that specifically targets the insulin-like growth factor 1 receptor (IGF1R) . it functions by competitively inhibiting the binding of IGF1 to its receptor with a IC50 of 1.8 nM. Figitumumab can be used in studies about advanced squamous cell carcinoma of the lung.

IGF-1R

Tyrosine Kinase/Adaptors

943406

0.991

-20°C

Ice Packs

Inhibitory Antibodies